Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication

J Hou, XT Li, KP Xie - Molecular Cancer, 2021 - Springer
Early detection and diagnosis are the key to successful clinical management of pancreatic
cancer and improve the patient outcome. However, due to the absence of early symptoms …

Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation

K Wang, X Wang, Q Pan, B Zhao - Molecular cancer, 2023 - Springer
Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a
potential curative approach for PC, but most patients are unsuitable for operations when at …

Liquid biopsies for management of pancreatic cancer

M Samandari, MG Julia, A Rice, A Chronopoulos… - Translational …, 2018 - Elsevier
Pancreatic cancer is one of the main causes of cancer-related deaths worldwide. It is
asymptomatic at an early stage, and most diagnosis occurs when the disease is already at a …

[HTML][HTML] The significance of liquid biopsy in pancreatic cancer

ZH Qi, HX Xu, SR Zhang, JZ Xu, S Li, HL Gao… - Journal of …, 2018 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of cancer. The 5-
year survival rate for PDAC remains low because it is always diagnosed at an advanced …

[HTML][HTML] Liquid biopsy in pancreatic cancer: the beginning of a new era

DK Yadav, X Bai, RK Yadav, A Singh, G Li, T Ma… - Oncotarget, 2018 - ncbi.nlm.nih.gov
With dismal survival rate pancreatic cancer remains one of the most aggressive and
devastating malignancy. Predominantly, due to the absence of a dependable methodology …

Liquid biopsy in pancreatic cancer–Current perspective and future outlook

Y Zhao, J Tang, K Jiang, SY Liu, A Aicher… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Pancreatic cancer is a lethal condition with a rising incidence and often presents at an
advanced stage, contributing to abysmal five-year survival rates. Unspecific symptoms and …

Advances in liquid biopsy technology and implications for pancreatic cancer

AG Raufi, MS May, MJ Hadfield, AA Seyhan… - International journal of …, 2023 - mdpi.com
Pancreatic cancer is a highly aggressive malignancy with a climbing incidence. The majority
of cases are detected late, with incurable locally advanced or metastatic disease. Even in …

Liquid biopsy approach for pancreatic ductal adenocarcinoma

E Buscail, C Maulat, F Muscari, L Chiche, P Cordelier… - Cancers, 2019 - mdpi.com
Pancreatic cancer is a public health problem because of its increasing incidence, the
absence of early diagnostic tools, and its aggressiveness. Despite recent progress in …

Liquid biopsy in pancreatic cancer: Are we ready to apply it in the clinical practice?

V Heredia-Soto, N Rodríguez-Salas, J Feliu - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the tumors with the
highest mortality, for which survival has hardly changed in the last 40 years. This high …

Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis

NH Stoecklein, G Fluegen, R Guglielmi, RPL Neves… - Molecular Cancer, 2023 - Springer
The limited sensitivity of circulating tumor cell (CTC) detection in pancreatic
adenocarcinoma (PDAC) stems from their extremely low concentration in the whole …